"The United States has already invested in developing curative therapies. Without a financing model that matches their value, those cures will remain out of reach for many patients," writes USC Schaeffer's William Padula in @statnews.com.
“We do not lack cures. We lack the infrastructure to pay for and deliver them,” writes William Padula.
